Work

Supplementary Table S1 from Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy

Year: 2023

Type: supplementary-materials

Abstract: Supplemental Table S1: CDK12 and CDK13 inhibitors and their properties, including in vitro potencies and structures.

DOI: 10.1158/2159-8290.22534994

Authors: Jonathan Chou, David A. Quigley, Troy M. Robinson, Felix Y. Feng, Alan Ashworth

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362617627

Cites:

Cited by:

Related to: 10